Ocugen announces 2-year safety and efficacy update for Phase 1/2 OCU400 for the treatment of RP
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO
Rayner launches redesign of IOL calculator RayTrace
You and Eye: Myopia cannot be viewed as a specialty in today's practice setting
Revo partners with Launchpad Vision for new direct sales structure in optical channel
City Therapeutics and Bausch + Lomb join forces for GA treatment candidate